Connect MM® – the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide

Robert M. Rifkin; Rafat Abonour; Jatin J. Shah; Jayesh Mehta; Mohit Narang; Howard Terebelo; Cristina Gasparetto; Kathleen Toomey; James W. Hardin; Jane Jie Lu; Laurie Kenvin; Shankar Srinivasan; Robert Knight; Yasir Nagarwala; Brian G.M. Durie

doi:10.3109/10428194.2015.1132419

Connect MM® – the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide

Robert M. Rifkin, Rafat Abonour, Jatin J. Shah, Jayesh Mehta, Mohit Narang, Howard Terebelo, Cristina Gasparetto, Kathleen Toomey, James W. Hardin, Jane Jie Lu, Laurie Kenvin, Shankar Srinivasan, Robert Knight, Yasir Nagarwala, Brian G.M. Durie

Lymphoma-Myeloma

Research output: Contribution to journal › Letter › peer-review

17 Scopus citations

Original language	English (US)
Pages (from-to)	2228-2231
Number of pages	4
Journal	Leukemia and Lymphoma
Volume	57
Issue number	9
DOIs	https://doi.org/10.3109/10428194.2015.1132419
State	Published - Sep 1 2016

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.3109/10428194.2015.1132419

Cite this

Rifkin, R. M., Abonour, R., Shah, J. J., Mehta, J., Narang, M., Terebelo, H., Gasparetto, C., Toomey, K., Hardin, J. W., Lu, J. J., Kenvin, L., Srinivasan, S., Knight, R., Nagarwala, Y., & Durie, B. G. M. (2016). Connect MM® – the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide. Leukemia and Lymphoma, 57(9), 2228-2231. https://doi.org/10.3109/10428194.2015.1132419

Rifkin, RM, Abonour, R, Shah, JJ, Mehta, J, Narang, M, Terebelo, H, Gasparetto, C, Toomey, K, Hardin, JW, Lu, JJ, Kenvin, L, Srinivasan, S, Knight, R, Nagarwala, Y & Durie, BGM 2016, 'Connect MM® – the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide', Leukemia and Lymphoma, vol. 57, no. 9, pp. 2228-2231. https://doi.org/10.3109/10428194.2015.1132419

@article{ec82abec10c24fb9badf135aee0e0771,

title = "Connect MM{\textregistered} – the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide",

author = "Rifkin, {Robert M.} and Rafat Abonour and Shah, {Jatin J.} and Jayesh Mehta and Mohit Narang and Howard Terebelo and Cristina Gasparetto and Kathleen Toomey and Hardin, {James W.} and Lu, {Jane Jie} and Laurie Kenvin and Shankar Srinivasan and Robert Knight and Yasir Nagarwala and Durie, {Brian G.M.}",

year = "2016",

month = sep,

day = "1",

doi = "10.3109/10428194.2015.1132419",

language = "English (US)",

volume = "57",

pages = "2228--2231",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "9",

}

TY - JOUR

T1 - Connect MM® – the Multiple Myeloma Disease Registry

T2 - incidence of second primary malignancies in patients treated with lenalidomide

AU - Rifkin, Robert M.

AU - Abonour, Rafat

AU - Shah, Jatin J.

AU - Mehta, Jayesh

AU - Narang, Mohit

AU - Terebelo, Howard

AU - Gasparetto, Cristina

AU - Toomey, Kathleen

AU - Hardin, James W.

AU - Lu, Jane Jie

AU - Kenvin, Laurie

AU - Srinivasan, Shankar

AU - Knight, Robert

AU - Nagarwala, Yasir

AU - Durie, Brian G.M.

PY - 2016/9/1

Y1 - 2016/9/1

UR - http://www.scopus.com/inward/record.url?scp=84954305960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954305960&partnerID=8YFLogxK

U2 - 10.3109/10428194.2015.1132419

DO - 10.3109/10428194.2015.1132419

M3 - Letter

C2 - 26766599

AN - SCOPUS:84954305960

SN - 1042-8194

VL - 57

SP - 2228

EP - 2231

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 9

ER -

Connect MM® – the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this